Ancor 5 mg Tablet - 10's strip
৳ 100
Quantity:
1
SKU: T2M0755
Order By Call:
+88 01540 384 786 (Mobile)
+88 01819 479 004 (WhatsApp)
Payment Methods
About the Product
Full Description
\n
\n
\n \n
\n \n
\n \n
\nBisoprolol Fumarate is the most selective beta-1 blocker. It has highest level of affinity for the beta-1 receptor than any other beta-blocker available up to now. It selectively blocks beta-1 adrenergic receptor in the heart and vascular smooth muscle and reduces heart rate and cardiac output resulting in decrease of arterial hypertension. Lipid metabolism can be adversely affected by beta-1 blockers, in patients with non-selective beta-blocker, but Bisoprolol does not cause any change in the cholesterol fraction including the cardioprotective HDL-cholesterol in long-term therapy.
\n \n
\n \n
\n \n
\n \n \n
\nPresentation:
\nAncor-2.5 Tablet: Each tablet contains Bisoprolol Fumarate USP 2.5 mg. Ancor-5 Tablet: Each tablet contains Bisoprolol Fumarate USP 5 mg. Ancor-10 Tablet: Each tablet contains Bisoprolol Fumarate USP 10 mg.
\n \n \n
\nIndication:
\nHypertension, angina and adjunct in stable moderate to severe heart failure
\n \n \n
\nDosage & Administration:
\nHypertension and angina: Usually 5-10 mg once daily, max. 20 mg daily, Moderate to severe heart failure: Initially 1.25 mg once daily (in the morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily; max.10 mg daily.
\n \n \n
\nContrainidications:
\nIn patients with cardiogenic shock, overt heart failure, second or third degree A-V block, right ventricular failure secondary to pulmonary hypertension and sinus bradycardia.
\n \n \n
\nWarning & Precautions:
\nMonitoring of renal, hepatic, and hematopoietic function should be performed at regular intervals during long-term treatment with bisoprolol.
\n \n \n
\nSide effects:
\nGastro-intestinal disturbances, bradycardia, hypotension, peripheral vasoconstriction, headache, fatigue, sleep disturbances, dizziness, vertigo, sexual dysfunction; thrombocytopenia; visual disturbances, alopecia may be occurred.
\n \n \n
\nDrug interaction:
\nBisoprolol should not be combined with other beta-blocking agents.
\n \n \n
\nUse in special groups:
\nUse in pregnancy: The safety of bisoprolol during pregnancy has not been established Use in lactation: No data is available for lactation. Use in children: Safety and effectiveness in children have not been established.
\n \n \n
\nPacking:
\nAncor-2.5 Tablet: Each box contains 30’s tablets in blister pack. Ancor-5 Tablet: Each box contains 30’s tablets in blister pack. Ancor-10 Tablet: Each box contains 10’s tablets in blister pack
\nReviews:
No Review
Releted Products
